Global Neuronal Markers Market Growth 2025-2031

April 2025 | 84 pages | ID: G3A6F42A8FF5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Neuronal Markers market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.

United States market for Neuronal Markers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Neuronal Markers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Neuronal Markers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Neuronal Markers players cover Athena Diagnostics, Myriad RBM, AbaStar MDx, QIAGEN, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Neuronal Markers Industry Forecast” looks at past sales and reviews total world Neuronal Markers sales in 2024, providing a comprehensive analysis by region and market sector of projected Neuronal Markers sales for 2025 through 2031. With Neuronal Markers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuronal Markers industry.

This Insight Report provides a comprehensive analysis of the global Neuronal Markers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuronal Markers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuronal Markers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuronal Markers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuronal Markers.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuronal Markers market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Imaging Biomarkers
• Metabolomics Biomarkers
• Proteomic Biomarkers
• Genomics Biomarkers

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Athena Diagnostics
• Myriad RBM
• AbaStar MDx
• QIAGEN
• Thermo Fisher Scientific

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neuronal Markers market?

What factors are driving Neuronal Markers market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neuronal Markers market opportunities vary by end market size?

How does Neuronal Markers break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neuronal Markers Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Neuronal Markers by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Neuronal Markers by Country/Region, 2020, 2024 & 2031
2.2 Neuronal Markers Segment by Type
  2.2.1 Imaging Biomarkers
  2.2.2 Metabolomics Biomarkers
  2.2.3 Proteomic Biomarkers
  2.2.4 Genomics Biomarkers
2.3 Neuronal Markers Sales by Type
  2.3.1 Global Neuronal Markers Sales Market Share by Type (2020-2025)
  2.3.2 Global Neuronal Markers Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Neuronal Markers Sale Price by Type (2020-2025)
2.4 Neuronal Markers Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Neuronal Markers Sales by Application
  2.5.1 Global Neuronal Markers Sale Market Share by Application (2020-2025)
  2.5.2 Global Neuronal Markers Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Neuronal Markers Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Neuronal Markers Breakdown Data by Company
  3.1.1 Global Neuronal Markers Annual Sales by Company (2020-2025)
  3.1.2 Global Neuronal Markers Sales Market Share by Company (2020-2025)
3.2 Global Neuronal Markers Annual Revenue by Company (2020-2025)
  3.2.1 Global Neuronal Markers Revenue by Company (2020-2025)
  3.2.2 Global Neuronal Markers Revenue Market Share by Company (2020-2025)
3.3 Global Neuronal Markers Sale Price by Company
3.4 Key Manufacturers Neuronal Markers Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Neuronal Markers Product Location Distribution
  3.4.2 Players Neuronal Markers Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NEURONAL MARKERS BY GEOGRAPHIC REGION

4.1 World Historic Neuronal Markers Market Size by Geographic Region (2020-2025)
  4.1.1 Global Neuronal Markers Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Neuronal Markers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neuronal Markers Market Size by Country/Region (2020-2025)
  4.2.1 Global Neuronal Markers Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Neuronal Markers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neuronal Markers Sales Growth
4.4 APAC Neuronal Markers Sales Growth
4.5 Europe Neuronal Markers Sales Growth
4.6 Middle East & Africa Neuronal Markers Sales Growth

5 AMERICAS

5.1 Americas Neuronal Markers Sales by Country
  5.1.1 Americas Neuronal Markers Sales by Country (2020-2025)
  5.1.2 Americas Neuronal Markers Revenue by Country (2020-2025)
5.2 Americas Neuronal Markers Sales by Type (2020-2025)
5.3 Americas Neuronal Markers Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neuronal Markers Sales by Region
  6.1.1 APAC Neuronal Markers Sales by Region (2020-2025)
  6.1.2 APAC Neuronal Markers Revenue by Region (2020-2025)
6.2 APAC Neuronal Markers Sales by Type (2020-2025)
6.3 APAC Neuronal Markers Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Neuronal Markers by Country
  7.1.1 Europe Neuronal Markers Sales by Country (2020-2025)
  7.1.2 Europe Neuronal Markers Revenue by Country (2020-2025)
7.2 Europe Neuronal Markers Sales by Type (2020-2025)
7.3 Europe Neuronal Markers Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neuronal Markers by Country
  8.1.1 Middle East & Africa Neuronal Markers Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Neuronal Markers Revenue by Country (2020-2025)
8.2 Middle East & Africa Neuronal Markers Sales by Type (2020-2025)
8.3 Middle East & Africa Neuronal Markers Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuronal Markers
10.3 Manufacturing Process Analysis of Neuronal Markers
10.4 Industry Chain Structure of Neuronal Markers

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Neuronal Markers Distributors
11.3 Neuronal Markers Customer

12 WORLD FORECAST REVIEW FOR NEURONAL MARKERS BY GEOGRAPHIC REGION

12.1 Global Neuronal Markers Market Size Forecast by Region
  12.1.1 Global Neuronal Markers Forecast by Region (2026-2031)
  12.1.2 Global Neuronal Markers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neuronal Markers Forecast by Type (2026-2031)
12.7 Global Neuronal Markers Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Athena Diagnostics
  13.1.1 Athena Diagnostics Company Information
  13.1.2 Athena Diagnostics Neuronal Markers Product Portfolios and Specifications
  13.1.3 Athena Diagnostics Neuronal Markers Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Athena Diagnostics Main Business Overview
  13.1.5 Athena Diagnostics Latest Developments
13.2 Myriad RBM
  13.2.1 Myriad RBM Company Information
  13.2.2 Myriad RBM Neuronal Markers Product Portfolios and Specifications
  13.2.3 Myriad RBM Neuronal Markers Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Myriad RBM Main Business Overview
  13.2.5 Myriad RBM Latest Developments
13.3 AbaStar MDx
  13.3.1 AbaStar MDx Company Information
  13.3.2 AbaStar MDx Neuronal Markers Product Portfolios and Specifications
  13.3.3 AbaStar MDx Neuronal Markers Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 AbaStar MDx Main Business Overview
  13.3.5 AbaStar MDx Latest Developments
13.4 QIAGEN
  13.4.1 QIAGEN Company Information
  13.4.2 QIAGEN Neuronal Markers Product Portfolios and Specifications
  13.4.3 QIAGEN Neuronal Markers Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 QIAGEN Main Business Overview
  13.4.5 QIAGEN Latest Developments
13.5 Thermo Fisher Scientific
  13.5.1 Thermo Fisher Scientific Company Information
  13.5.2 Thermo Fisher Scientific Neuronal Markers Product Portfolios and Specifications
  13.5.3 Thermo Fisher Scientific Neuronal Markers Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Thermo Fisher Scientific Main Business Overview
  13.5.5 Thermo Fisher Scientific Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neuronal Markers Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neuronal Markers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Imaging Biomarkers
Table 4. Major Players of Metabolomics Biomarkers
Table 5. Major Players of Proteomic Biomarkers
Table 6. Major Players of Genomics Biomarkers
Table 7. Global Neuronal Markers Sales by Type (2020-2025) & (K Units)
Table 8. Global Neuronal Markers Sales Market Share by Type (2020-2025)
Table 9. Global Neuronal Markers Revenue by Type (2020-2025) & ($ million)
Table 10. Global Neuronal Markers Revenue Market Share by Type (2020-2025)
Table 11. Global Neuronal Markers Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Neuronal Markers Sale by Application (2020-2025) & (K Units)
Table 13. Global Neuronal Markers Sale Market Share by Application (2020-2025)
Table 14. Global Neuronal Markers Revenue by Application (2020-2025) & ($ million)
Table 15. Global Neuronal Markers Revenue Market Share by Application (2020-2025)
Table 16. Global Neuronal Markers Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Neuronal Markers Sales by Company (2020-2025) & (K Units)
Table 18. Global Neuronal Markers Sales Market Share by Company (2020-2025)
Table 19. Global Neuronal Markers Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Neuronal Markers Revenue Market Share by Company (2020-2025)
Table 21. Global Neuronal Markers Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Neuronal Markers Producing Area Distribution and Sales Area
Table 23. Players Neuronal Markers Products Offered
Table 24. Neuronal Markers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Neuronal Markers Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Neuronal Markers Sales Market Share Geographic Region (2020-2025)
Table 29. Global Neuronal Markers Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Neuronal Markers Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Neuronal Markers Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Neuronal Markers Sales Market Share by Country/Region (2020-2025)
Table 33. Global Neuronal Markers Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Neuronal Markers Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Neuronal Markers Sales by Country (2020-2025) & (K Units)
Table 36. Americas Neuronal Markers Sales Market Share by Country (2020-2025)
Table 37. Americas Neuronal Markers Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Neuronal Markers Sales by Type (2020-2025) & (K Units)
Table 39. Americas Neuronal Markers Sales by Application (2020-2025) & (K Units)
Table 40. APAC Neuronal Markers Sales by Region (2020-2025) & (K Units)
Table 41. APAC Neuronal Markers Sales Market Share by Region (2020-2025)
Table 42. APAC Neuronal Markers Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Neuronal Markers Sales by Type (2020-2025) & (K Units)
Table 44. APAC Neuronal Markers Sales by Application (2020-2025) & (K Units)
Table 45. Europe Neuronal Markers Sales by Country (2020-2025) & (K Units)
Table 46. Europe Neuronal Markers Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Neuronal Markers Sales by Type (2020-2025) & (K Units)
Table 48. Europe Neuronal Markers Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Neuronal Markers Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Neuronal Markers Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Neuronal Markers Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Neuronal Markers Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Neuronal Markers
Table 54. Key Market Challenges & Risks of Neuronal Markers
Table 55. Key Industry Trends of Neuronal Markers
Table 56. Neuronal Markers Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Neuronal Markers Distributors List
Table 59. Neuronal Markers Customer List
Table 60. Global Neuronal Markers Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Neuronal Markers Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Neuronal Markers Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Neuronal Markers Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Neuronal Markers Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Neuronal Markers Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Neuronal Markers Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Neuronal Markers Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Neuronal Markers Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Neuronal Markers Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Neuronal Markers Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Neuronal Markers Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Neuronal Markers Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Neuronal Markers Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Athena Diagnostics Basic Information, Neuronal Markers Manufacturing Base, Sales Area and Its Competitors
Table 75. Athena Diagnostics Neuronal Markers Product Portfolios and Specifications
Table 76. Athena Diagnostics Neuronal Markers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Athena Diagnostics Main Business
Table 78. Athena Diagnostics Latest Developments
Table 79. Myriad RBM Basic Information, Neuronal Markers Manufacturing Base, Sales Area and Its Competitors
Table 80. Myriad RBM Neuronal Markers Product Portfolios and Specifications
Table 81. Myriad RBM Neuronal Markers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. Myriad RBM Main Business
Table 83. Myriad RBM Latest Developments
Table 84. AbaStar MDx Basic Information, Neuronal Markers Manufacturing Base, Sales Area and Its Competitors
Table 85. AbaStar MDx Neuronal Markers Product Portfolios and Specifications
Table 86. AbaStar MDx Neuronal Markers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. AbaStar MDx Main Business
Table 88. AbaStar MDx Latest Developments
Table 89. QIAGEN Basic Information, Neuronal Markers Manufacturing Base, Sales Area and Its Competitors
Table 90. QIAGEN Neuronal Markers Product Portfolios and Specifications
Table 91. QIAGEN Neuronal Markers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. QIAGEN Main Business
Table 93. QIAGEN Latest Developments
Table 94. Thermo Fisher Scientific Basic Information, Neuronal Markers Manufacturing Base, Sales Area and Its Competitors
Table 95. Thermo Fisher Scientific Neuronal Markers Product Portfolios and Specifications
Table 96. Thermo Fisher Scientific Neuronal Markers Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Thermo Fisher Scientific Main Business
Table 98. Thermo Fisher Scientific Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Neuronal Markers
Figure 2. Neuronal Markers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuronal Markers Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neuronal Markers Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neuronal Markers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neuronal Markers Sales Market Share by Country/Region (2024)
Figure 10. Neuronal Markers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Imaging Biomarkers
Figure 12. Product Picture of Metabolomics Biomarkers
Figure 13. Product Picture of Proteomic Biomarkers
Figure 14. Product Picture of Genomics Biomarkers
Figure 15. Global Neuronal Markers Sales Market Share by Type in 2025
Figure 16. Global Neuronal Markers Revenue Market Share by Type (2020-2025)
Figure 17. Neuronal Markers Consumed in Hospital
Figure 18. Global Neuronal Markers Market: Hospital (2020-2025) & (K Units)
Figure 19. Neuronal Markers Consumed in Clinic
Figure 20. Global Neuronal Markers Market: Clinic (2020-2025) & (K Units)
Figure 21. Neuronal Markers Consumed in Others
Figure 22. Global Neuronal Markers Market: Others (2020-2025) & (K Units)
Figure 23. Global Neuronal Markers Sale Market Share by Application (2024)
Figure 24. Global Neuronal Markers Revenue Market Share by Application in 2025
Figure 25. Neuronal Markers Sales by Company in 2025 (K Units)
Figure 26. Global Neuronal Markers Sales Market Share by Company in 2025
Figure 27. Neuronal Markers Revenue by Company in 2025 ($ millions)
Figure 28. Global Neuronal Markers Revenue Market Share by Company in 2025
Figure 29. Global Neuronal Markers Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Neuronal Markers Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Neuronal Markers Sales 2020-2025 (K Units)
Figure 32. Americas Neuronal Markers Revenue 2020-2025 ($ millions)
Figure 33. APAC Neuronal Markers Sales 2020-2025 (K Units)
Figure 34. APAC Neuronal Markers Revenue 2020-2025 ($ millions)
Figure 35. Europe Neuronal Markers Sales 2020-2025 (K Units)
Figure 36. Europe Neuronal Markers Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Neuronal Markers Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Neuronal Markers Revenue 2020-2025 ($ millions)
Figure 39. Americas Neuronal Markers Sales Market Share by Country in 2025
Figure 40. Americas Neuronal Markers Revenue Market Share by Country (2020-2025)
Figure 41. Americas Neuronal Markers Sales Market Share by Type (2020-2025)
Figure 42. Americas Neuronal Markers Sales Market Share by Application (2020-2025)
Figure 43. United States Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Neuronal Markers Sales Market Share by Region in 2025
Figure 48. APAC Neuronal Markers Revenue Market Share by Region (2020-2025)
Figure 49. APAC Neuronal Markers Sales Market Share by Type (2020-2025)
Figure 50. APAC Neuronal Markers Sales Market Share by Application (2020-2025)
Figure 51. China Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 55. India Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Neuronal Markers Sales Market Share by Country in 2025
Figure 59. Europe Neuronal Markers Revenue Market Share by Country (2020-2025)
Figure 60. Europe Neuronal Markers Sales Market Share by Type (2020-2025)
Figure 61. Europe Neuronal Markers Sales Market Share by Application (2020-2025)
Figure 62. Germany Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 63. France Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Neuronal Markers Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Neuronal Markers Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Neuronal Markers Sales Market Share by Application (2020-2025)
Figure 70. Egypt Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Neuronal Markers Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Neuronal Markers in 2025
Figure 76. Manufacturing Process Analysis of Neuronal Markers
Figure 77. Industry Chain Structure of Neuronal Markers
Figure 78. Channels of Distribution
Figure 79. Global Neuronal Markers Sales Market Forecast by Region (2026-2031)
Figure 80. Global Neuronal Markers Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Neuronal Markers Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Neuronal Markers Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Neuronal Markers Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Neuronal Markers Revenue Market Share Forecast by Application (2026-2031)